Skip to content

Study of the Impact of Freezing-thawing Procedures and the Prolonged Culture of Embryos on Epigenetic Regulation in Humans

Study of the Impact of Freezing-thawing Procedures and the Prolonged Culture of Embryos on Epigenetic Regulation in Humans

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02171884
Enrollment
298
Registered
2014-06-24
Start date
2013-01-17
Completion date
2022-05-02
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Assisted Reproductive Technology, Freezing/Thawing Procedure, Prolonged Culture Procedure

Brief summary

For this project, 4 groups of 38 infants have been created so as to evaluate the impact of Assisted-Reproduction Technology (ART) and more particularly the two procedures classically used in ART: the freezing/thawing of embryos and prolonged embryo culture (five days of culture in appropriate in vitro conditions to allow development of the embryo) in contrast with shorter culture of only two days. Participation consists in accepting samples to be taken at the birth of the infant: 1. from the umbilical cord. 2. from the placenta.

Interventions

OTHERSample of cord blood
OTHERSample of placenta

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients who have provided written informed consent, * Patients with national health insurance cover, * Maternal age at conception between 20 and 43 years, * Paternal age at conception between 18 and 50 years, * Singleton pregnancy

Exclusion criteria

---Maternal disease: * pulmonary, cardiac * renal and metabolic diseases (including type 1 and 2 diabetes prior to the pregnancy) * systemic inflammatory diseases * hypertension * neurological diseases * chronic hepatitis B or C * HIV infection

Design outcomes

Primary

MeasureTime frameDescription
Analysis of the expression of several genes subjected to imprinting (H19, IGF2, IGF2R, MEST, PEG3, SNRPN, IGF2, KCNQ1, GRB10 and PLAGL1)BaselinesDNA / RNA extraction
Analysis of the expression of 3 transposable elements (HERV-K, LINE-1 and ALU)BaselinesDNA / RNA extraction
Level of methylation and the level of expression of Genomic Imprinting (GI) and Transposable Elements (TE)BaselinesDNA / RNA extraction

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026